J.P. Morgan cuts Alcon to 'neutral' on 2026 growth concerns

** J.P. Morgan cuts the Swiss-American eye care company Alcon ALC to "neutral" from "overweight", citing weak quarterly results and lowered outlook , raising concerns over 2026 growth

** Alcon will see additional headwinds in 2026 due to a likely dilution from recent M&A and annualization of tariffs, the brokerage adds

** "Market growth acceleration and evidence of successful new product launches could see us reverse this cut to the premium – but for the next six months, this seems unlikely," JPM says

** The shares will require evidence of acceleration to work, the broker says, which is unlikely to happen before Q4 results at the earliest

** The stock is down 1.4% in Swiss pre-market trade

** Out of 18 analysts that cover Alcon AG, 14 rate the stock "strong buy" or "buy,"​three rate "hold" and one rates the stock "sell" - LSEG data